Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
Hutcheson, Iain R
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1. [electronic resource] - Breast cancer research : BCR Mar 2011 - R29 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr2848 doi
Breast Neoplasms--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Cyclin D1--biosynthesis
Drug Resistance, Neoplasm
ErbB Receptors--biosynthesis
Estradiol--analogs & derivatives
Estrogen Receptor Modulators--pharmacology
Female
Fulvestrant
Humans
Intracellular Signaling Peptides and Proteins--metabolism
Neuregulin-1--metabolism
Receptor, ErbB-3--metabolism
Receptor, ErbB-4
Receptors, Estrogen--metabolism
Signal Transduction--drug effects
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1. [electronic resource] - Breast cancer research : BCR Mar 2011 - R29 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr2848 doi
Breast Neoplasms--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Cyclin D1--biosynthesis
Drug Resistance, Neoplasm
ErbB Receptors--biosynthesis
Estradiol--analogs & derivatives
Estrogen Receptor Modulators--pharmacology
Female
Fulvestrant
Humans
Intracellular Signaling Peptides and Proteins--metabolism
Neuregulin-1--metabolism
Receptor, ErbB-3--metabolism
Receptor, ErbB-4
Receptors, Estrogen--metabolism
Signal Transduction--drug effects